<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">64116</article-id><article-id pub-id-type="doi">10.7554/eLife.64116</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Evolutionary Biology</subject></subj-group></article-categories><title-group><article-title>Multi-step vs. single-step resistance evolution under different drugs, pharmacokinetics and treatment regimens</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-211547"><name><surname>Igler</surname><given-names>Claudia</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7777-546X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-79434"><name><surname>Rolff</surname><given-names>Jens</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1529-5409</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-32219"><name><surname>Regoes</surname><given-names>Roland</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8319-5293</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Theoretical Biology</institution>, <institution>ETH Zurich</institution>, <addr-line><named-content content-type="city">Zurich</named-content></addr-line>, <country>Switzerland</country></aff><aff id="aff2"><institution content-type="dept">Institute for Biology</institution>, <institution>Freie Universität Berlin</institution>, <addr-line><named-content content-type="city">Berlin</named-content></addr-line>, <country>Germany</country></aff><aff id="aff3"><institution content-type="dept">Institute of Integrative Biology</institution>, <institution>ETH Zurich</institution>, <addr-line><named-content content-type="city">Zurich</named-content></addr-line>, <country>Switzerland</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-34498"><name><surname>Cooper</surname><given-names>Ben S</given-names></name><role>Reviewing editor</role><aff><institution>Mahidol University</institution>, <country>Thailand</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>claudia.igler@env.ethz.ch</email> (CI);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>roland.regoes@env.ethz.ch</email> (RR);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>18</day><month>05</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e64116</elocation-id><history><date date-type="received"><day>18</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>04</day><month>05</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Igler et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Igler et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-64116-v1.pdf"/><abstract><p>The success of antimicrobial treatment is threatened by the evolution of drug resistance. Population genetic models are an important tool in mitigating that threat. However, most such models consider resistance emergence via a single mutational step. Here, we assembled experimental evidence that drug resistance evolution follows two patterns: i) a single mutation, which provides a large resistance benefit, or ii) multiple mutations, each conferring a small benefit, which combine to yield high-level resistance. Using stochastic modeling we then investigated the consequences of these two patterns for treatment failure and population diversity under various treatments. We find that resistance evolution is substantially limited if more than two mutations are required and that the extent of this limitation depends on the combination of drug type and pharmacokinetic profile. Further, if multiple mutations are necessary, adaptive treatment, which only suppresses the bacterial population, delays treatment failure due to resistance for a longer time than aggressive treatment, which aims at eradication.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>None</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001663</institution-id><institution>Volkswagen Foundation</institution></institution-wrap></funding-source><award-id>96517</award-id><principal-award-recipient><name><surname>Igler</surname><given-names>Claudia</given-names></name><name><surname>Rolff</surname><given-names>Jens</given-names></name><name><surname>Regoes</surname><given-names>Roland</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data and code generated or analysed during this study are included in the manuscript and supporting files. Source code has been provided for Figures 2-4, as well as S2-S17 in the form of an R package. Source data has been provided for Table 1, Figure 1B and S1.</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Melnyk A</collab><collab>Wong A</collab><collab>Kassen R</collab></person-group><year iso-8601-date="2015">2015</year><source>The fitness costs of antibiotic resistance mutations</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.5rc47">https://doi.org/10.5061/dryad.5rc47</ext-link><comment>Dryad Digital Repository: http://doi.org/10.5061/dryad.5rc47</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-64116-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>